Cefoperazone (sodium salt): Broad Spectrum β-Lactamase-Stable Cephalosporin for Resistant Gram-Negative Bacilli

Executive Summary: Cefoperazone (sodium salt) is a broad spectrum, β-lactamase-resistant cephalosporin antibiotic effective against gram-positive and gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, and Proteus species (Cullmann et al., 1982). It demonstrates minimal differences between MIC and MBC values under clinical and laboratory conditions, with MIC₅₀ values as low as ≤0.004–0.06 μg/ml for Neisseria gonorrhoeae (APExBIO, C3913). The compound shows high in vivo stability, especially in bile and gall bladder tissues, supporting use in biliary tract infection models (Tcephydrochloride, 2023). Its resistance to cephalosporinase hydrolysis (relative rates 7.0–0.01) enables robust performance in antibacterial resistance studies. Cefoperazone sodium salt is supplied as a crystalline solid, stored at -20°C, and is highly soluble in DMSO and water but insoluble in ethanol (APExBIO, C3913).

Biological Rationale

Cefoperazone (sodium salt) is a third-generation semisynthetic cephalosporin antibiotic designed for broad spectrum antibacterial activity. Its molecular structure (C₂₅H₂₆N₉O₈S₂·Na, MW 667.7) confers high affinity for penicillin-binding proteins and resistance to β-lactamase enzymes produced by gram-negative bacteria (Cullmann et al., 1982). The antibiotic is effective in both in vitro and in vivo models against clinically relevant pathogens such as Escherichia coli, Klebsiella pneumoniae, and Proteus species. Its stability in biological fluids, especially bile, enables selective targeting of biliary tract infections (APExBIO, C3913).

Mechanism of Action of Cefoperazone (sodium salt)

Cefoperazone acts by binding to penicillin-binding proteins (PBPs) on the bacterial cell wall, inhibiting transpeptidase activity and thus peptidoglycan crosslinking, resulting in cell lysis and death (Cullmann et al., 1982). Unlike earlier β-lactams, cefoperazone is highly stable against hydrolysis by β-lactamases, particularly cephalosporinases. Relative hydrolysis rates by cephalosporinases range from 7.0 to 0.01, reflecting strong resistance to enzymatic degradation. This property allows cefoperazone to retain activity in the presence of β-lactamase-producing gram-negative bacilli. The minimal difference between MIC and MBC in laboratory studies underscores its potent bactericidal mechanism (APExBIO, C3913).

Evidence & Benchmarks

• Cefoperazone (sodium salt) demonstrates MIC₅₀ values against Neisseria gonorrhoeae strains ranging from ≤0.004 to 0.06 μg/ml (Cullmann et al., DOI).
• It exhibits high stability against β-lactamase hydrolysis, with cephalosporinase hydrolysis rates as low as 0.01 relative units (APExBIO, C3913).
• In broth dilution susceptibility tests, cefoperazone inhibits clinical isolates of Escherichia coli, Klebsiella spp., and Proteus spp. at concentrations between 0.125–8 μg/ml (Cullmann et al., DOI).
• Pharmacokinetic studies show high biliary excretion and tissue concentration after intravenous administration, supporting use in biliary tract infection models (APExBIO, C3913).
• Minimal difference between MIC and MBC values in vitro, indicating reliable bactericidal action (Cullmann et al., DOI).

This article updates 'Cefoperazone Sodium Salt: Benchmarking Gram-Negative Anti...' by providing detailed molecular stability and comparative data. For advanced mechanistic insights, see 'Cefoperazone Sodium Salt: Mechanisms and Innovations in O...', which this article extends with new evidence on cephalosporinase resistance. For a focus on workflow optimization and reproducibility, 'Solving Gram-Negative Assay Challenges with Cefoperazone ...' is available; here, we provide updated performance benchmarks and clarify real-world limitations.

Applications, Limits & Misconceptions

Cefoperazone (sodium salt) is widely used in:

• In vitro antimicrobial susceptibility assays for gram-negative and gram-positive bacteria.
• Modeling resistance mechanisms involving β-lactamase- and cephalosporinase-producing bacteria.
• Pharmacokinetic studies, especially biliary tract infection research.
• Comparative antibiotic research and MIC/MBC benchmarking.

However, its spectrum is not universal and there are scenarios where cefoperazone is less effective, particularly in the presence of specific resistance mechanisms or in certain bacterial species. For more on its scope and advanced applications, see 'Cefoperazone (sodium salt): Broad-Spectrum β-Lactamase-St...', which this article clarifies by specifying quantitative limits and providing updated stability data.

Common Pitfalls or Misconceptions

• Cefoperazone (sodium salt) is not effective against all β-lactamase-producing bacteria; metallo-β-lactamases and some carbapenemases can confer resistance (Cullmann et al., 1982).
• It is not active against Pseudomonas aeruginosa to the same degree as some other β-lactams (e.g., N-formimidoyl thienamycin) (Table 1).
• Stock solutions degrade over time, especially at room temperature; prompt use and storage at -20°C are required (APExBIO).
• It is insoluble in ethanol, requiring DMSO or water for solution preparation (APExBIO, C3913).
• Clinical use data should not be extrapolated directly from in vitro or animal models without further validation.

Workflow Integration & Parameters

Cefoperazone (sodium salt) is supplied as a crystalline solid by APExBIO (SKU: C3913). It is soluble at ≥73 mg/mL in DMSO and ≥34.6 mg/mL in water; ethanol is unsuitable. Stock solutions should be prepared at ≤20 mg/mL in DMSO, with optional warming and ultrasonic treatment to enhance solubility. Storage at -20°C is mandatory. Solutions should be used promptly and not stored long-term to prevent degradation. For in vitro antimicrobial activity assay, standard broth dilution or microtiter plate workflows are recommended. Recommended inoculum is 5 × 10⁵ CFU/mL in Mueller-Hinton broth (Cullmann et al., 1982). For advanced guidance on integrating this compound into resistance workflows and cell viability assays, see 'Solving Gram-Negative Assay Challenges with Cefoperazone ...'.

Conclusion & Outlook

Cefoperazone (sodium salt) is a robust, β-lactamase-resistant cephalosporin with proven efficacy against a spectrum of gram-negative and gram-positive bacteria. Its stability and pharmacokinetic properties make it a preferred reagent for resistance mechanism studies and in vitro antimicrobial benchmarking. Limitations exist with certain resistance types and storage requirements, but with careful workflow integration, it remains an indispensable tool for research in antibiotic resistance and infection models. For procurement and detailed specifications, refer to the APExBIO Cefoperazone (sodium salt) product page.